SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO)
TWD 92.3
(-9.95%)
TWD 92.3
(-9.95%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 127.67 Million TWD | -1.67% |
| 2022 | 122.75 Million TWD | 6.34% |
| 2021 | 115.42 Million TWD | 12.85% |
| 2020 | 102.28 Million TWD | 4.17% |
| 2019 | 98.19 Million TWD | 3.1% |
| 2018 | 95.24 Million TWD | 2.67% |
| 2017 | 92.76 Million TWD | -13.31% |
| 2016 | 107.01 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 28.36 Million TWD | -11.51% |
| 2024 Q2 | 33.67 Million TWD | 25.37% |
| 2023 FY | 120.69 Million TWD | -1.67% |
| 2023 Q1 | 27.89 Million TWD | -23.52% |
| 2023 Q2 | 29.06 Million TWD | 4.19% |
| 2023 Q4 | 32.05 Million TWD | 1.18% |
| 2023 Q3 | 31.67 Million TWD | 8.98% |
| 2022 Q1 | 20.44 Million TWD | -6.14% |
| 2022 Q4 | 36.47 Million TWD | 19.47% |
| 2022 Q3 | 30.53 Million TWD | 41.33% |
| 2022 Q2 | 21.6 Million TWD | 5.68% |
| 2022 FY | 122.75 Million TWD | 6.34% |
| 2021 Q3 | 18.28 Million TWD | 0.0% |
| 2021 FY | 115.42 Million TWD | 12.85% |
| 2021 Q4 | 21.78 Million TWD | 19.15% |
| 2020 FY | 102.28 Million TWD | 4.17% |
| 2019 FY | 98.19 Million TWD | 3.1% |
| 2018 FY | 95.24 Million TWD | 2.67% |
| 2017 FY | 92.76 Million TWD | -13.31% |
| 2016 FY | 107.01 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -38705.471% |
| Level Biotechnology Inc. | 151.99 Million TWD | 16.003% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 6.023% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | -68.299% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 43.316% |
| GlycoNex Incorporation | 995 Thousand TWD | -12731.156% |
| VBI | 32.55 Million TWD | -292.167% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 50.298% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 34.254% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -177.405% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -6.472% |
| Visgeneer Inc. | 67.48 Million TWD | -89.191% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 134.028% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 74.971% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -99.787% |
| Neith Corporation | 66.87 Million TWD | -90.914% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 91.159% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -334.962% |
| Enimmune corporation | 220.1 Million TWD | 41.995% |
| TaiRx, Inc. | 217.13 Million TWD | 41.202% |
| CHO Pharma, Inc. | 268.99 Million TWD | 52.539% |
| EirGenix Inc. | 236.74 Million TWD | 46.072% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -22.347% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 64.3% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 88.36% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 52.032% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | -158.07% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -11688.55% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 28.053% |
| RBC Bioscience Corporation | 58.35 Million TWD | -118.778% |
| BiOptic Inc. | 108.69 Million TWD | -17.46% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -141755.556% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -84.095% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -4782.218% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 80.173% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -36.785% |
| NaviFUS Corp. | 11.82 Million TWD | -979.479% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 33.062% |
| Sinew Pharma Inc. | 186.25 Million TWD | 31.453% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -72.473% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 42.073% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -207.779% |
| AP Biosciences Inc | 32.25 Million TWD | -295.839% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 93.1% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -2320.743% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 59.767% |
| Intech Biopharm Corporation | -163.99 Million TWD | 177.85% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 88.694% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -207.772% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 24.703% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 13.163% |
| TCI GENE Inc. | 174.61 Million TWD | 26.886% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -709177.778% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 57.576% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 56.121% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -52.088% |
| PharmaEngine, Inc. | 441.78 Million TWD | 71.102% |
| Savior Lifetec Corporation | 223.36 Million TWD | 42.843% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 50.664% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 93.668% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 8.065% |
| Acepodia, Inc. | 452.56 Million TWD | 71.79% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 76.398% |